Urothelial AGR2 expression was 40 times lower than prostate cancer AGR2 expression as calculated from the array signal intensity values for AGR2 in CD9+ urothelial cells and sorted CD26+ prostate cancer cells (Figure 1B). This evidence concerns the gene DPP4 and prostate carcinoma.